nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Loss of consciousness—Sorafenib—thyroid cancer	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Asthenia—Vandetanib—thyroid cancer	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Coordination abnormal—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Gemifloxacin—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Gemifloxacin—Pruritus—Vandetanib—thyroid cancer	0.00164	0.00164	CcSEcCtD
Gemifloxacin—Arthralgia—Sorafenib—thyroid cancer	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Myalgia—Sorafenib—thyroid cancer	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Glossitis—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Vaginal inflammation—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Abnormal dreams—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Gemifloxacin—Dry mouth—Sorafenib—thyroid cancer	0.00159	0.00159	CcSEcCtD
Gemifloxacin—Eructation—Epirubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Gemifloxacin—Diarrhoea—Vandetanib—thyroid cancer	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Skin exfoliation—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Candida infection—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Shock—Sorafenib—thyroid cancer	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Nervous system disorder—Sorafenib—thyroid cancer	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Dizziness—Vandetanib—thyroid cancer	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Blood urea increased—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Vaginal infection—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Coordination abnormal—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Skin disorder—Sorafenib—thyroid cancer	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Anorexia—Sorafenib—thyroid cancer	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Gemifloxacin—Abnormal dreams—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Gemifloxacin—Vomiting—Vandetanib—thyroid cancer	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Eructation—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Mouth ulceration—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Gemifloxacin—Rash—Vandetanib—thyroid cancer	0.00146	0.00146	CcSEcCtD
Gemifloxacin—Dermatitis—Vandetanib—thyroid cancer	0.00146	0.00146	CcSEcCtD
Gemifloxacin—Headache—Vandetanib—thyroid cancer	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Skin exfoliation—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Gemifloxacin—Candida infection—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Blood urea increased—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Vaginal infection—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Abnormal vision—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Dyspnoea—Sorafenib—thyroid cancer	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Nausea—Vandetanib—thyroid cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Dyspepsia—Sorafenib—thyroid cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Decreased appetite—Sorafenib—thyroid cancer	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Mouth ulceration—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Fatigue—Sorafenib—thyroid cancer	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Photosensitivity—Epirubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Pain—Sorafenib—thyroid cancer	0.00133	0.00133	CcSEcCtD
Gemifloxacin—Constipation—Sorafenib—thyroid cancer	0.00133	0.00133	CcSEcCtD
Gemifloxacin—Eczema—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Abnormal vision—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Renal failure acute—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Hot flush—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Menopausal symptoms—Epirubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Urticaria—Sorafenib—thyroid cancer	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Photosensitivity—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Abdominal pain—Sorafenib—thyroid cancer	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Body temperature increased—Sorafenib—thyroid cancer	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Eczema—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Gemifloxacin—Hyponatraemia—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Renal failure acute—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Hot flush—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Gemifloxacin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Gemifloxacin—Face oedema—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Asthenia—Sorafenib—thyroid cancer	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Pruritus—Sorafenib—thyroid cancer	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Hyponatraemia—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Diarrhoea—Sorafenib—thyroid cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Breast disorder—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Face oedema—Doxorubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Gastritis—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Dizziness—Sorafenib—thyroid cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Dysphagia—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Eosinophilia—Epirubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Gemifloxacin—Pancreatitis—Epirubicin—thyroid cancer	0.000993	0.000993	CcSEcCtD
Gemifloxacin—Vomiting—Sorafenib—thyroid cancer	0.000991	0.000991	CcSEcCtD
Gemifloxacin—Rash—Sorafenib—thyroid cancer	0.000983	0.000983	CcSEcCtD
Gemifloxacin—Dermatitis—Sorafenib—thyroid cancer	0.000982	0.000982	CcSEcCtD
Gemifloxacin—Breast disorder—Doxorubicin—thyroid cancer	0.00098	0.00098	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000977	0.000977	CcSEcCtD
Gemifloxacin—Headache—Sorafenib—thyroid cancer	0.000977	0.000977	CcSEcCtD
Gemifloxacin—Gastritis—Doxorubicin—thyroid cancer	0.00096	0.00096	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000957	0.000957	CcSEcCtD
Gemifloxacin—Dysphagia—Doxorubicin—thyroid cancer	0.000938	0.000938	CcSEcCtD
Gemifloxacin—Eosinophilia—Doxorubicin—thyroid cancer	0.000928	0.000928	CcSEcCtD
Gemifloxacin—Nausea—Sorafenib—thyroid cancer	0.000926	0.000926	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000925	0.000925	CcSEcCtD
Gemifloxacin—Pancreatitis—Doxorubicin—thyroid cancer	0.000919	0.000919	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Epirubicin—thyroid cancer	0.000914	0.000914	CcSEcCtD
Gemifloxacin—Pneumonia—Epirubicin—thyroid cancer	0.000909	0.000909	CcSEcCtD
Gemifloxacin—Infestation NOS—Epirubicin—thyroid cancer	0.000903	0.000903	CcSEcCtD
Gemifloxacin—Infestation—Epirubicin—thyroid cancer	0.000903	0.000903	CcSEcCtD
Gemifloxacin—Renal failure—Epirubicin—thyroid cancer	0.000888	0.000888	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000886	0.000886	CcSEcCtD
Gemifloxacin—Stomatitis—Epirubicin—thyroid cancer	0.000881	0.000881	CcSEcCtD
Gemifloxacin—Haematuria—Epirubicin—thyroid cancer	0.000861	0.000861	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000856	0.000856	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000854	0.000854	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000846	0.000846	CcSEcCtD
Gemifloxacin—Agranulocytosis—Epirubicin—thyroid cancer	0.000843	0.000843	CcSEcCtD
Gemifloxacin—Pneumonia—Doxorubicin—thyroid cancer	0.000841	0.000841	CcSEcCtD
Gemifloxacin—Infestation NOS—Doxorubicin—thyroid cancer	0.000836	0.000836	CcSEcCtD
Gemifloxacin—Infestation—Doxorubicin—thyroid cancer	0.000836	0.000836	CcSEcCtD
Gemifloxacin—Renal failure—Doxorubicin—thyroid cancer	0.000822	0.000822	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000819	0.000819	CcSEcCtD
Gemifloxacin—Haemoglobin—Epirubicin—thyroid cancer	0.000815	0.000815	CcSEcCtD
Gemifloxacin—Stomatitis—Doxorubicin—thyroid cancer	0.000815	0.000815	CcSEcCtD
Gemifloxacin—Haemorrhage—Epirubicin—thyroid cancer	0.000811	0.000811	CcSEcCtD
Gemifloxacin—Pharyngitis—Epirubicin—thyroid cancer	0.000805	0.000805	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Epirubicin—thyroid cancer	0.000801	0.000801	CcSEcCtD
Gemifloxacin—Oedema peripheral—Epirubicin—thyroid cancer	0.000799	0.000799	CcSEcCtD
Gemifloxacin—Haematuria—Doxorubicin—thyroid cancer	0.000797	0.000797	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000797	0.000797	CcSEcCtD
Gemifloxacin—Urethral disorder—Epirubicin—thyroid cancer	0.000795	0.000795	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000791	0.000791	CcSEcCtD
Gemifloxacin—Visual impairment—Epirubicin—thyroid cancer	0.000782	0.000782	CcSEcCtD
Gemifloxacin—Agranulocytosis—Doxorubicin—thyroid cancer	0.00078	0.00078	CcSEcCtD
Gemifloxacin—Erythema multiforme—Epirubicin—thyroid cancer	0.000767	0.000767	CcSEcCtD
Gemifloxacin—Eye disorder—Epirubicin—thyroid cancer	0.000758	0.000758	CcSEcCtD
Gemifloxacin—Haemoglobin—Doxorubicin—thyroid cancer	0.000754	0.000754	CcSEcCtD
Gemifloxacin—Flushing—Epirubicin—thyroid cancer	0.000753	0.000753	CcSEcCtD
Gemifloxacin—Cardiac disorder—Epirubicin—thyroid cancer	0.000753	0.000753	CcSEcCtD
Gemifloxacin—Haemorrhage—Doxorubicin—thyroid cancer	0.00075	0.00075	CcSEcCtD
Gemifloxacin—Pharyngitis—Doxorubicin—thyroid cancer	0.000745	0.000745	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000741	0.000741	CcSEcCtD
Gemifloxacin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000739	0.000739	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000737	0.000737	CcSEcCtD
Gemifloxacin—Angiopathy—Epirubicin—thyroid cancer	0.000736	0.000736	CcSEcCtD
Gemifloxacin—Urethral disorder—Doxorubicin—thyroid cancer	0.000736	0.000736	CcSEcCtD
Gemifloxacin—Immune system disorder—Epirubicin—thyroid cancer	0.000733	0.000733	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000731	0.000731	CcSEcCtD
Gemifloxacin—Visual impairment—Doxorubicin—thyroid cancer	0.000723	0.000723	CcSEcCtD
Gemifloxacin—Mental disorder—Epirubicin—thyroid cancer	0.000711	0.000711	CcSEcCtD
Gemifloxacin—Erythema multiforme—Doxorubicin—thyroid cancer	0.00071	0.00071	CcSEcCtD
Gemifloxacin—Eye disorder—Doxorubicin—thyroid cancer	0.000701	0.000701	CcSEcCtD
Gemifloxacin—Flushing—Doxorubicin—thyroid cancer	0.000696	0.000696	CcSEcCtD
Gemifloxacin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000696	0.000696	CcSEcCtD
Gemifloxacin—Flatulence—Epirubicin—thyroid cancer	0.000696	0.000696	CcSEcCtD
Gemifloxacin—Tension—Epirubicin—thyroid cancer	0.000693	0.000693	CcSEcCtD
Gemifloxacin—Dysgeusia—Epirubicin—thyroid cancer	0.000691	0.000691	CcSEcCtD
Gemifloxacin—Nervousness—Epirubicin—thyroid cancer	0.000686	0.000686	CcSEcCtD
Gemifloxacin—Back pain—Epirubicin—thyroid cancer	0.000683	0.000683	CcSEcCtD
Gemifloxacin—Angiopathy—Doxorubicin—thyroid cancer	0.000681	0.000681	CcSEcCtD
Gemifloxacin—Muscle spasms—Epirubicin—thyroid cancer	0.000679	0.000679	CcSEcCtD
Gemifloxacin—Immune system disorder—Doxorubicin—thyroid cancer	0.000678	0.000678	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000676	0.000676	CcSEcCtD
Gemifloxacin—Mental disorder—Doxorubicin—thyroid cancer	0.000657	0.000657	CcSEcCtD
Gemifloxacin—Anaemia—Epirubicin—thyroid cancer	0.000653	0.000653	CcSEcCtD
Gemifloxacin—Flatulence—Doxorubicin—thyroid cancer	0.000644	0.000644	CcSEcCtD
Gemifloxacin—Tension—Doxorubicin—thyroid cancer	0.000641	0.000641	CcSEcCtD
Gemifloxacin—Dysgeusia—Doxorubicin—thyroid cancer	0.00064	0.00064	CcSEcCtD
Gemifloxacin—Nervousness—Doxorubicin—thyroid cancer	0.000634	0.000634	CcSEcCtD
Gemifloxacin—Vertigo—Epirubicin—thyroid cancer	0.000634	0.000634	CcSEcCtD
Gemifloxacin—Syncope—Epirubicin—thyroid cancer	0.000633	0.000633	CcSEcCtD
Gemifloxacin—Leukopenia—Epirubicin—thyroid cancer	0.000632	0.000632	CcSEcCtD
Gemifloxacin—Back pain—Doxorubicin—thyroid cancer	0.000632	0.000632	CcSEcCtD
Gemifloxacin—Muscle spasms—Doxorubicin—thyroid cancer	0.000628	0.000628	CcSEcCtD
Gemifloxacin—Palpitations—Epirubicin—thyroid cancer	0.000624	0.000624	CcSEcCtD
Gemifloxacin—Loss of consciousness—Epirubicin—thyroid cancer	0.000621	0.000621	CcSEcCtD
Gemifloxacin—Anaemia—Doxorubicin—thyroid cancer	0.000604	0.000604	CcSEcCtD
Gemifloxacin—Myalgia—Epirubicin—thyroid cancer	0.000601	0.000601	CcSEcCtD
Gemifloxacin—Arthralgia—Epirubicin—thyroid cancer	0.000601	0.000601	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000597	0.000597	CcSEcCtD
Gemifloxacin—Dry mouth—Epirubicin—thyroid cancer	0.000588	0.000588	CcSEcCtD
Gemifloxacin—Vertigo—Doxorubicin—thyroid cancer	0.000587	0.000587	CcSEcCtD
Gemifloxacin—Syncope—Doxorubicin—thyroid cancer	0.000586	0.000586	CcSEcCtD
Gemifloxacin—Leukopenia—Doxorubicin—thyroid cancer	0.000585	0.000585	CcSEcCtD
Gemifloxacin—Palpitations—Doxorubicin—thyroid cancer	0.000577	0.000577	CcSEcCtD
Gemifloxacin—Oedema—Epirubicin—thyroid cancer	0.000576	0.000576	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000576	0.000576	CcSEcCtD
Gemifloxacin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000574	0.000574	CcSEcCtD
Gemifloxacin—Shock—Epirubicin—thyroid cancer	0.000567	0.000567	CcSEcCtD
Gemifloxacin—Nervous system disorder—Epirubicin—thyroid cancer	0.000565	0.000565	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000564	0.000564	CcSEcCtD
Gemifloxacin—Tachycardia—Epirubicin—thyroid cancer	0.000562	0.000562	CcSEcCtD
Gemifloxacin—Skin disorder—Epirubicin—thyroid cancer	0.00056	0.00056	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000557	0.000557	CcSEcCtD
Gemifloxacin—Myalgia—Doxorubicin—thyroid cancer	0.000556	0.000556	CcSEcCtD
Gemifloxacin—Arthralgia—Doxorubicin—thyroid cancer	0.000556	0.000556	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000552	0.000552	CcSEcCtD
Gemifloxacin—Anorexia—Epirubicin—thyroid cancer	0.000549	0.000549	CcSEcCtD
Gemifloxacin—Dry mouth—Doxorubicin—thyroid cancer	0.000544	0.000544	CcSEcCtD
Gemifloxacin—Oedema—Doxorubicin—thyroid cancer	0.000533	0.000533	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000533	0.000533	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000525	0.000525	CcSEcCtD
Gemifloxacin—Shock—Doxorubicin—thyroid cancer	0.000525	0.000525	CcSEcCtD
Gemifloxacin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000523	0.000523	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000522	0.000522	CcSEcCtD
Gemifloxacin—Insomnia—Epirubicin—thyroid cancer	0.000521	0.000521	CcSEcCtD
Gemifloxacin—Tachycardia—Doxorubicin—thyroid cancer	0.00052	0.00052	CcSEcCtD
Gemifloxacin—Skin disorder—Doxorubicin—thyroid cancer	0.000518	0.000518	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000515	0.000515	CcSEcCtD
Gemifloxacin—Dyspnoea—Epirubicin—thyroid cancer	0.000514	0.000514	CcSEcCtD
Gemifloxacin—Somnolence—Epirubicin—thyroid cancer	0.000512	0.000512	CcSEcCtD
Gemifloxacin—Anorexia—Doxorubicin—thyroid cancer	0.000508	0.000508	CcSEcCtD
Gemifloxacin—Dyspepsia—Epirubicin—thyroid cancer	0.000507	0.000507	CcSEcCtD
Gemifloxacin—Decreased appetite—Epirubicin—thyroid cancer	0.000501	0.000501	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000497	0.000497	CcSEcCtD
Gemifloxacin—Fatigue—Epirubicin—thyroid cancer	0.000497	0.000497	CcSEcCtD
Gemifloxacin—Constipation—Epirubicin—thyroid cancer	0.000493	0.000493	CcSEcCtD
Gemifloxacin—Pain—Epirubicin—thyroid cancer	0.000493	0.000493	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000486	0.000486	CcSEcCtD
Gemifloxacin—Insomnia—Doxorubicin—thyroid cancer	0.000482	0.000482	CcSEcCtD
Gemifloxacin—Dyspnoea—Doxorubicin—thyroid cancer	0.000475	0.000475	CcSEcCtD
Gemifloxacin—Somnolence—Doxorubicin—thyroid cancer	0.000474	0.000474	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000471	0.000471	CcSEcCtD
Gemifloxacin—Dyspepsia—Doxorubicin—thyroid cancer	0.000469	0.000469	CcSEcCtD
Gemifloxacin—Decreased appetite—Doxorubicin—thyroid cancer	0.000463	0.000463	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00046	0.00046	CcSEcCtD
Gemifloxacin—Fatigue—Doxorubicin—thyroid cancer	0.00046	0.00046	CcSEcCtD
Gemifloxacin—Urticaria—Epirubicin—thyroid cancer	0.000458	0.000458	CcSEcCtD
Gemifloxacin—Constipation—Doxorubicin—thyroid cancer	0.000456	0.000456	CcSEcCtD
Gemifloxacin—Pain—Doxorubicin—thyroid cancer	0.000456	0.000456	CcSEcCtD
Gemifloxacin—Abdominal pain—Epirubicin—thyroid cancer	0.000456	0.000456	CcSEcCtD
Gemifloxacin—Body temperature increased—Epirubicin—thyroid cancer	0.000456	0.000456	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000436	0.000436	CcSEcCtD
Gemifloxacin—Urticaria—Doxorubicin—thyroid cancer	0.000424	0.000424	CcSEcCtD
Gemifloxacin—Body temperature increased—Doxorubicin—thyroid cancer	0.000421	0.000421	CcSEcCtD
Gemifloxacin—Abdominal pain—Doxorubicin—thyroid cancer	0.000421	0.000421	CcSEcCtD
Gemifloxacin—Asthenia—Epirubicin—thyroid cancer	0.000413	0.000413	CcSEcCtD
Gemifloxacin—Pruritus—Epirubicin—thyroid cancer	0.000408	0.000408	CcSEcCtD
Gemifloxacin—Diarrhoea—Epirubicin—thyroid cancer	0.000394	0.000394	CcSEcCtD
Gemifloxacin—Asthenia—Doxorubicin—thyroid cancer	0.000383	0.000383	CcSEcCtD
Gemifloxacin—Dizziness—Epirubicin—thyroid cancer	0.000381	0.000381	CcSEcCtD
Gemifloxacin—Pruritus—Doxorubicin—thyroid cancer	0.000377	0.000377	CcSEcCtD
Gemifloxacin—Vomiting—Epirubicin—thyroid cancer	0.000366	0.000366	CcSEcCtD
Gemifloxacin—Diarrhoea—Doxorubicin—thyroid cancer	0.000365	0.000365	CcSEcCtD
Gemifloxacin—Rash—Epirubicin—thyroid cancer	0.000363	0.000363	CcSEcCtD
Gemifloxacin—Dermatitis—Epirubicin—thyroid cancer	0.000363	0.000363	CcSEcCtD
Gemifloxacin—Headache—Epirubicin—thyroid cancer	0.000361	0.000361	CcSEcCtD
Gemifloxacin—Dizziness—Doxorubicin—thyroid cancer	0.000353	0.000353	CcSEcCtD
Gemifloxacin—Nausea—Epirubicin—thyroid cancer	0.000342	0.000342	CcSEcCtD
Gemifloxacin—Vomiting—Doxorubicin—thyroid cancer	0.000339	0.000339	CcSEcCtD
Gemifloxacin—Rash—Doxorubicin—thyroid cancer	0.000336	0.000336	CcSEcCtD
Gemifloxacin—Dermatitis—Doxorubicin—thyroid cancer	0.000336	0.000336	CcSEcCtD
Gemifloxacin—Headache—Doxorubicin—thyroid cancer	0.000334	0.000334	CcSEcCtD
Gemifloxacin—Nausea—Doxorubicin—thyroid cancer	0.000317	0.000317	CcSEcCtD
